In the pond of DNA microarray providers relying on in situ synthesis, Affymetrix is still the biggest fish. But some smaller fry believe they will be able to snatch away a few juicy bites from their big brother: Xeotron, with a unique combination of photo-generated reagents, digital photolithography, and microfluidics, is poised to enter the market for custom-made DNA arrays, and is already thinking about testing new waters with its peptide arrays.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.